GLENMARK LIFE SCIENCES
Back to Income Statement
|
GLENMARK LIFE SCIENCES Last 5 Year Consolidated Net Profit History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹467 Cr | ₹419 Cr | ₹352 Cr | ₹313 Cr | ₹196 Cr |
What is the latest Consolidated Net Profit of GLENMARK LIFE SCIENCES ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹467 Cr |
Mar2022 | ₹419 Cr |
Mar2021 | ₹352 Cr |
Mar2020 | ₹313 Cr |
Mar2019 | ₹196 Cr |
How is Consolidated Net Profit of GLENMARK LIFE SCIENCES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹467 Cr | 11.52 | |
Mar2022 | ₹419 Cr | 19.10 | |
Mar2021 | ₹352 Cr | 12.29 | |
Mar2020 | ₹313 Cr | 60.08 | |
Mar2019 | ₹196 Cr | - |
Compare Consolidated Net Profit of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹10,156.5 Cr | 0.4% | 7% | 75.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | 0.4% |
7% |
75.9% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses